Univariate analysis of risk factors in 78 patients with SLE. Only significant results are reported
| Predictors | Hypertension | Renal disease at T1 | ECLAM >2 at T1 | PDN ⩾40 g | Azathioprine | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | ||||||
| T1, baseline; ECLAM, European Consensus Lupus Activity Measurement score; PDN, prednisone cumulative dose; M-IMT, maximum IMT; m-IMT, mean IMT. | |||||||||||||||
| *p<0.05; | |||||||||||||||
| †p<0.03; | |||||||||||||||
| ‡p<0.02; | |||||||||||||||
| §p=0.006; | |||||||||||||||
| ∥p=0.002; | |||||||||||||||
| ¶p<0.0005. | |||||||||||||||
| Plaque (%) | 31.4 | ∥ | 4.6 | 37.5 | ‡ | 11.2 | 25.5 | ‡ | 5.7 | 25.6 | * | 7.6 | 32.1 | § | 8.0 |
| Thickened intima (%) | 48.5 | ¶ | 11.6 | 50 | * | 22.5 | 39.5 | ‡ | 14.2 | 35.8 | 20.5 | 42.8 | * | 20.0 | |
| M-IMT (mean (SD) | 0.92 (0.41) | ¶ | 0.66 (0.20) | 0.95 (0.50) | ‡ | 0.73 (0.27) | 0.85 (0.41) | * | 0.68 (0.19 | 0.89 (0.47) | * | 0.72 (0.26) | 0.89 (0.43) | † | 0.71 (0.26) |
| m-IMT (mean (SD) | 0.63 (0.18) | ¶ | 0.49 (0.08) | 0.61 (0.16) | 0.54 (0.15) | 0.59 (0.18) | † | 0.51 (0.10 | 0.57 (0.17) | 0.55 (0.15) | 0.58 (0.16) | 0.54 (0.15) | |||